84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]孫龍?zhí)?姚華海,王曉洛,等.強骨飲對假體周圍骨溶解模型大鼠骨密度的影響及其作用機制研究[J].中醫(yī)正骨,2017,29(09):19-22.
　SUN Longtai,YAO Huahai,WANG Xiaoluo,et al.Effect of Qianggu Yin(強骨飲)on bone density of peri-prosthetic osteolysis rat models and its mechanism of action[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(09):19-22.
點擊復制

強骨飲對假體周圍骨溶解模型大鼠骨密度的影響及其作用機制研究()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第29卷
期數(shù):
2017年09期
頁碼:
19-22
欄目:
基礎研究
出版日期:
2017-09-20

文章信息/Info

Title:
Effect of Qianggu Yin(強骨飲)on bone density of peri-prosthetic osteolysis rat models and its mechanism of action
作者:
姚華海1; 王曉洛1; 崔龍慷1; 吳連國2
1.浙江中醫(yī)藥大學,浙江 杭州 310053; 2.浙江中醫(yī)藥大學附屬第二醫(yī)院,浙江 杭州 310005
Author(s):
SUN Longtai1; YAO Huahai1; WANG Xiaoluo1; CUI Longkang1; WU Lianguo2
1.Zhejiang Chinese Medical University,Hangzhou 310053,Zhejiang,China 2.The Second Affiliated Hospital of Zhengjiang Chinese Medical University,Hangzhou 310005,Zhejiang,China
關鍵詞:
關節(jié)成形術; 置換;  強骨飲;  骨質(zhì)溶解;  假體失效;  骨密度;  大鼠; Sprague-Dawley;  動物實驗
Keywords:
Key words arthroplasty; replacement;  Qianggu Yin;  osteolysis;  prosthesis failure;  bone density;  rats; Sprague-Dawley;  animal experimentation
摘要:
目的:探討強骨飲對假體周圍骨溶解模型大鼠骨密度的影響及其作用機制。方法:選取30只成年雄性SD大鼠,隨機分為空白組、模型組和強骨飲組,每組10只。空白組不進行造模; 模型組和強骨飲組大鼠右側(cè)股骨植入高密度聚乙烯顆粒和鈦棒,制備聚乙烯顆粒誘導的假體周圍骨溶解模型。造模手術3 d后,強骨飲組大鼠以制備好的強骨飲藥液灌胃,每周3次,連續(xù)給藥11周。空白組和模型組均不進行藥物干預。造模后12周,取大鼠靜脈血用ELISA法測定血清抗酒石酸酸性磷酸酶5b(tartrate resistant acid phosphatase 5b,TRACP5b)水平,取右側(cè)股骨進行骨密度檢測,并以ELISA法測定股骨組織中腫瘤壞死因子-α(tumor necrosis factor α,TNF-α)水平。結(jié)果:實驗過程中各組大鼠日常行為無差別,精神狀況良好,反應靈敏,體質(zhì)量逐漸增加。模型組和強骨飲組大鼠術后1周切口愈合。實驗全過程中各組均無大鼠死亡。3組大鼠血清TRACP5b水平比較,差異有統(tǒng)計學意義[(1.83±0.42)U·L-1,(2.40±0.43)U·L-1,(1.90±0.28)U·L-1,F=9.323,P=0.002]。模型組血清TRACP5b水平高于空白組和強骨飲組(P=0.001; P=0.002)。3組大鼠股骨骨密度比較,差異有統(tǒng)計學意義[(0.162±0.009)g·cm-2,(0.119±0.010)g·cm-2,(0.140±0.007)g·cm-2,F=74.323,P=0.000]。模型組股骨骨密度低于空白組和強骨飲組(P=0.000; P=0.000)。3組大鼠股骨組織中TNF-α水平比較,差異有統(tǒng)計學意義[(70.21±8.83)pg·mL-1,(175.32±14.95)pg·mL-1,(129.73±12.86)pg·mL-1,F=160.242,P=0.000]。模型組股骨組織TNF-α水平高于空白組和強骨飲組(P=0.000; P=0.000)。結(jié)論:強骨飲可以增加假體周圍骨溶解模型大鼠的骨密度,其機制可能是通過減輕炎癥反應,抑制破骨細胞活性,從而減少假體周圍骨吸收。
Abstract:
ABSTRACT Objective:To explore the effects of Qianggu Yin(強骨飲,QGY)on bone density of peri-prosthetic osteolysis rat models and its mechanism of action.Methods:Thirty adult male SD rats were selected and randomly divided into blank group,model group and QGY group,10 cases in each group.High density polyethylene(HDPE)particles and titanium rods were implanted into the right femurs of rats in model group and QGY group to build the peri-prosthetic osteolysis models induced by HDPE particles.At 3 days after the molding operation,the rats in QGY group were intragastric administrated with prepared QGY,3 times a week for consecutive 11 weeks.No drug intervention were performed on rats in blank group and model group.At 12 weeks after the modeling,the venous blood were fetched out and the serum levels of tartrate resistant acid phosphatase 5b(TRACP5b)were measured by using ELISA.The right femurs were taken from rats for detecting the bone densities,and the levels of tumor necrosis factor α(TNF-α)in femoral tissues were measured by using ELISA.Results:There were no difference in the daily actions of rats between the 3 groups during the course of experiment.The rats were in good mental states and rapid response and their body masses gradually increased.The incisions of rats in model group and QGY group were healed at 1 week after the surgery.No rats died in each group during the experiment.There was statistical difference in the serum levels of TRACP5b between the 3 groups(1.83+/-0.42,2.40+/-0.43,1.90+/-0.28 U/L,F=9.323,P=0.002).The serum levels of TRACP5b were higher in model group compared to blank group and QGY group(P=0.001; P=0.002).There was statistical difference in the femoral bone density between the 3 groups(0.162+/-0.009,0.119+/-0.010,0.140+/-0.007 g/cm(2),F=74.323,P=0.000).The femoral bone densities were lower in model group compared to blank group and QGY group(P=0.000; P=0.000).There was statistical difference in the TNF-α levels in femoral tissues between the 3 groups(70.21+/-8.83,175.32+/-14.95,129.73+/-12.86 pg/ml,F=160.242,P=0.000).The TNF-α levels in femoral tissues were higher in model group compared to blank group and QGY group(P=0.000; P=0.000).Conclusion:QGY can alleviate the inflammatory reaction and inhibit the cytoactive of osteoclasts and accordingly reduce peri-prosthetic bone resorption,which may be its mechanisms of action for increasing bone density of peri-prosthetic osteolysis rat models.

參考文獻/References:

[1] SANTAMBROGIO L.Biomaterials in Regenerative Medicine and the Immune System[M].Berlin:Springer International Publishing,2015:225-256. [2] JIN S,PARK JY,HONG JM,et al.Inhibitory effect of(-)-epigallocatechin gallate on titanium particle-induced TNF-α release and in vivo osteolysis[J].Exp Mol Med,2011,43(7):411-418. [3] LIU XQ,QU XH,WU CL,et al.The effect of enoxacin on osteoclastogenesis and reduction of Titanium particle-induced osteolysis via suppression of JNK signaling pathway[J].Biomaterials,2014,35(22):5721-5730. [4] 吳連國,劉康,黃俊俊,等.強骨飲對股骨頸骨折患者人工股骨頭置換術后假體周圍骨密度的影響[J].中醫(yī)正骨,2014,26(4):15-18. [5] 吳連國,葉健,吳風晴.右歸飲對聚乙烯顆粒誘導破骨細胞性骨溶解的抑制作用[J].中國中醫(yī)骨傷科雜志,2015,23(11):1-4. [6] GALLO J,GOODMAN SB,KONTTINEN YT,et al.Osteolysis around total knee arthroplasty:A review of pathogenetic mechanisms[J].Acta Biomater,2013,9(9):8046-8058. [7] JIANG X,SATO T,YAO Z,et al.Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo[J].J Orthop Res,2016,34(1):58. [8] BURTON L,PAGET D,BINDER NB,et al.Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation[J].J Ortho Res,2013,31(1):73-80. [9] BAKER PN,JAMESON SS,DEEHAN DJ,et al.Mid-term equivalent survival of medial and lateral unicondylar knee replacement:an analysis of data from a National Joint Registry[J].J Bone Joint Surg Br,2012,94(12):1641-1648. [10] NICH C,GOODMAN SB.Role of macrophages in the biological reaction to wear debris from joint replacements[J].J Long Term Eff Med Implants,2014,24(4):259-265. [11] SUÑER S,BLADEN CL,GOWLAND N,et al.Investigation of wear and wear particles from a UHMWPE/multi-walled carbon nanotube nanocomposite for total joint replacements[J].Wear,2014,317(1/2):163-169. [12] 徐偉鋒,葉健,吳連國.強骨飲對骨質(zhì)疏松性股骨頸骨折患者全髖關節(jié)置換術后血清骨代謝生化指標和骨密度的影響[J].中醫(yī)正骨,2015,27(2):12-16. [13] ANDO K,MORI K,RÉDINI F,et al.RANKL/RANK/OPG:key therapeutic target in bone oncology[J].Curr Drug Discov Technol,2008,5(3):263-268. [14] TAMAKI J,IKI M,KADOWAKI E,et al.Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years:the Japanese Population-based Osteoporosis(JPOS)Cohort Study[J].Osteoporos Int,2013,24(3):887-897. [15] IWADATE H,KOBAYASHI H,KANNO T,et al.Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients[J].Int J Rheum Dis,2014,17(1):50-56. [16] KRUMPEL M,REITHMEIER A,SENGE T,et al.The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells[J].Exp Cell Res,2015,339(1):154-162.

相似文獻/References:

[1]邢金明.切開復位鎖定鋼板內(nèi)固定術和人工半肩關節(jié)置換術 治療老年肱骨近端復雜骨折的對比研究[J].中醫(yī)正骨,2015,27(08):11.
　XING Jinming.A retrospective trial of open reduction and locking plate internal fixation versus artificial shoulder hemiarthroplasty for complicated proximal humeral fractures in old patients[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):11.
[2]趙云昌.人工股骨頭置換治療老年粉碎性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2015,27(08):31.
[3]張明強.生物型加長柄半髖關節(jié)置換術治療 高齡不穩(wěn)定股骨轉(zhuǎn)子間骨折療效觀察[J].中醫(yī)正骨,2015,27(02):56.
[4]蔡云仙.圍手術期耳穴按壓聯(lián)合平衡針療法 在全膝關節(jié)置換術后鎮(zhèn)痛中的應用[J].中醫(yī)正骨,2015,27(06):41.
[5]喻長純,楊明路,王戰(zhàn)朝.不同手術方式治療脛骨平臺骨折畸形愈合的體會[J].中醫(yī)正骨,2015,27(03):37.
[6]魏瑄,宋樹春,王金良.術前精確測量和評估在全髖關節(jié)置換治療 成人發(fā)育性髖關節(jié)發(fā)育不良繼發(fā)骨關節(jié)炎中的價值[J].中醫(yī)正骨,2015,27(01):30.
[7]鮑榮華,陳曉東,王國平,等.Wagner Cone生物型假體置換結(jié)合經(jīng)股骨轉(zhuǎn)子下橫形截骨 治療CroweⅣ型成人發(fā)育性髖關節(jié)發(fā)育不良[J].中醫(yī)正骨,2015,27(01):33.
[8]喻長純,楊明路,王戰(zhàn)朝.同期髕骨脫位矯正術聯(lián)合全膝關節(jié)置換術治療 晚期膝骨關節(jié)炎合并習慣性髕骨脫位[J].中醫(yī)正骨,2015,27(01):41.
[9]武理國,沈軍,傅國海,等.人工肱骨頭置換治療老年肱骨近端復雜骨折[J].中醫(yī)正骨,2013,25(10):70.
[10]李國梁,韓廣普,閆國強,等.紅花化瘀湯薰蒸聯(lián)合理筋手法 在膝骨關節(jié)炎全膝關節(jié)置換術后康復中的應用[J].中醫(yī)正骨,2013,25(12):31.
　Li Guoliang*,Han Guangpu,Yan Guoqiang,et al.Clinical application of HONGHUAHUAYU decoctions steaming combined with sinew adjusting manipulation in the postoperative rehabilitation of total knee arthroplasty in patients with knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):31.
[11]樊慶陽,任凱晶.定制3D打印切模輔助全膝關節(jié)置換術治療 膝骨關節(jié)炎合并股骨干骨折畸形愈合[J].中醫(yī)正骨,2015,27(11):37.
[12]李翰林,童培建.利福平聯(lián)合用藥配合保留假體清創(chuàng)治療 人工關節(jié)置換術后早期感染及低毒性感染[J].中醫(yī)正骨,2015,27(09):56.
[13]劉曉雅,孫永強,劉國杰.主動快速康復鍛煉對全膝關節(jié)置換術后關節(jié)活動度的影響[J].中醫(yī)正骨,2015,27(09):73.
[14]張維平,康兩期,陳衛(wèi),等.全髖關節(jié)置換術圍手術期隱性失血的研究進展[J].中醫(yī)正骨,2015,27(08):61.
[15]宋兵華,孫俊英,倪增良,等.全膝關節(jié)置換術前CT測量股骨后髁角的臨床意義[J].中醫(yī)正骨,2015,27(07):38.
[16]王金良,孫京濤,李玲,等.骨水泥聯(lián)合螺釘修復全膝關節(jié)置換術中 脛骨平臺內(nèi)側(cè)骨缺損[J].中醫(yī)正骨,2015,27(12):55.
[17]徐偉鋒,葉健,吳連國.強骨飲對骨質(zhì)疏松性股骨頸骨折患者全髖關節(jié)置換術后 血清骨代謝生化指標和骨密度的影響[J].中醫(yī)正骨,2015,27(02):12.
　XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(強骨飲,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[18]張榮,王健.人工全膝關節(jié)置換術的圍手術期心理護理[J].中醫(yī)正骨,2015,27(05):77.
[19]齊志遠,陳秀民,王在斌,等.桃紅四物加黃芪湯預防人工髖膝關節(jié)置換術后 下肢深靜脈血栓形成[J].中醫(yī)正骨,2015,27(03):71.
[20]陸吳超,季衛(wèi)鋒,馬鎮(zhèn)川.關節(jié)鏡下清創(chuàng)后持續(xù)灌洗聯(lián)合中藥口服治療 全膝關節(jié)置換術后急性期感染[J].中醫(yī)正骨,2015,27(01):51.

備注/Memo

備注/Memo:
基金項目:浙江省一流學科(B類)建設項目; 浙江省科技廳公益技術應用研究計劃項目(2016C33128); 教育部高等學校博士學科點專項科研基金聯(lián)合資助課題(20133322120004) 通訊作者:吳連國 E-mail:[email protected]
更新日期/Last Update: 2018-02-23